P01.076 Experience with tumor treating fields (TTFields, Optune®) in Israel - patient compliance and adverse effects

BACKGROUND: TTFields are low intensity, intermediate frequency alternating electric fields, delivered through a portable, non-invasive device (Optune, Novocure(TM)). The EF-14 phase III trial showed significant prolongation of both progression-free and overall survival in newly diagnosed glioblastom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Siegal, T, Bokstein, F, Blumenthal, D T, Zach, L, Leibovici, A, Yust-Katz, S, Lossos, A, Tzuk-Shina, T, Lokiec, A, Ram, Z
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144114/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados